SELECT MEDICAL HOLDINGS CORP (SEM) Fundamental Analysis & Valuation
NYSE:SEM • US81619Q1058
Current stock price
16.39 USD
0 (0%)
Last:
This SEM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SEM Profitability Analysis
1.1 Basic Checks
- SEM had positive earnings in the past year.
- SEM had a positive operating cash flow in the past year.
- Each year in the past 5 years SEM has been profitable.
- In the past 5 years SEM always reported a positive cash flow from operatings.
1.2 Ratios
- SEM has a Return On Assets (2.44%) which is in line with its industry peers.
- SEM's Return On Equity of 8.38% is fine compared to the rest of the industry. SEM outperforms 64.00% of its industry peers.
- SEM has a Return On Invested Capital (5.27%) which is in line with its industry peers.
- The Average Return On Invested Capital over the past 3 years for SEM is below the industry average of 8.51%.
- The last Return On Invested Capital (5.27%) for SEM is above the 3 year average (4.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.44% | ||
| ROE | 8.38% | ||
| ROIC | 5.27% |
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
1.3 Margins
- SEM has a Profit Margin of 2.62%. This is in the better half of the industry: SEM outperforms 64.00% of its industry peers.
- SEM's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 6.17%, SEM is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
- SEM's Operating Margin has declined in the last couple of years.
- SEM has a Gross Margin of 11.54%. This is in the lower half of the industry: SEM underperforms 71.00% of its industry peers.
- In the last couple of years the Gross Margin of SEM has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.17% | ||
| PM (TTM) | 2.62% | ||
| GM | 11.54% |
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
2. SEM Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SEM is destroying value.
- The number of shares outstanding for SEM has been reduced compared to 1 year ago.
- Compared to 5 years ago, SEM has less shares outstanding
- Compared to 1 year ago, SEM has a worse debt to assets ratio.
2.2 Solvency
- SEM has an Altman-Z score of 1.62. This is a bad value and indicates that SEM is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of SEM (1.62) is comparable to the rest of the industry.
- The Debt to FCF ratio of SEM is 15.74, which is on the high side as it means it would take SEM, 15.74 years of fcf income to pay off all of its debts.
- SEM has a worse Debt to FCF ratio (15.74) than 63.00% of its industry peers.
- A Debt/Equity ratio of 1.07 is on the high side and indicates that SEM has dependencies on debt financing.
- SEM has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: SEM underperforms 63.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 15.74 | ||
| Altman-Z | 1.62 |
ROIC/WACC0.61
WACC8.65%
2.3 Liquidity
- A Current Ratio of 1.04 indicates that SEM should not have too much problems paying its short term obligations.
- SEM's Current ratio of 1.04 is on the low side compared to the rest of the industry. SEM is outperformed by 69.00% of its industry peers.
- SEM has a Quick Ratio of 1.04. This is a normal value and indicates that SEM is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.04, SEM is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.04 | ||
| Quick Ratio | 1.04 |
3. SEM Growth Analysis
3.1 Past
- The earnings per share for SEM have decreased strongly by -30.30% in the last year.
- Measured over the past years, SEM shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.36% on average per year.
- SEM shows a small growth in Revenue. In the last year, the Revenue has grown by 5.12%.
- SEM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.29% yearly.
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
3.2 Future
- Based on estimates for the next years, SEM will show a small growth in Earnings Per Share. The EPS will grow by 3.71% on average per year.
- SEM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.75% yearly.
EPS Next Y11.25%
EPS Next 2Y9.53%
EPS Next 3Y3.71%
EPS Next 5YN/A
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.75%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. SEM Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 14.25, which indicates a correct valuation of SEM.
- 82.00% of the companies in the same industry are more expensive than SEM, based on the Price/Earnings ratio.
- SEM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.18.
- The Price/Forward Earnings ratio is 12.81, which indicates a correct valuation of SEM.
- 81.00% of the companies in the same industry are more expensive than SEM, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 37.96. SEM is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.25 | ||
| Fwd PE | 12.81 |
4.2 Price Multiples
- SEM's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SEM is cheaper than 79.00% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of SEM indicates a somewhat cheap valuation: SEM is cheaper than 67.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.34 | ||
| EV/EBITDA | 8.05 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y9.53%
EPS Next 3Y3.71%
5. SEM Dividend Analysis
5.1 Amount
- SEM has a Yearly Dividend Yield of 1.53%.
- Compared to an average industry Dividend Yield of 0.47, SEM pays a better dividend. On top of this SEM pays more dividend than 89.00% of the companies listed in the same industry.
- SEM's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.53% |
5.2 History
- SEM has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- SEM pays out 21.99% of its income as dividend. This is a sustainable payout ratio.
DP21.99%
EPS Next 2Y9.53%
EPS Next 3Y3.71%
SEM Fundamentals: All Metrics, Ratios and Statistics
NYSE:SEM (4/14/2026, 1:05:01 PM)
16.39
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19 2026-02-19/amc
Earnings (Next)04-30 2026-04-30/amc
Inst Owners83.08%
Inst Owner Change0.15%
Ins Owners10.75%
Ins Owner Change0.41%
Market Cap2.03B
Revenue(TTM)5.45B
Net Income(TTM)142.92M
Analysts71.11
Price Target17.03 (3.9%)
Short Float %2.63%
Short Ratio1.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.53% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP21.99%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-02 2026-03-02 (0.0625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.41%
Min EPS beat(2)-31%
Max EPS beat(2)49.82%
EPS beat(4)2
Avg EPS beat(4)11.24%
Min EPS beat(4)-31%
Max EPS beat(4)49.82%
EPS beat(8)3
Avg EPS beat(8)-11.03%
EPS beat(12)7
Avg EPS beat(12)-1.92%
EPS beat(16)8
Avg EPS beat(16)-6.67%
Revenue beat(2)2
Avg Revenue beat(2)1.44%
Min Revenue beat(2)1.43%
Max Revenue beat(2)1.45%
Revenue beat(4)2
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.45%
Revenue beat(8)4
Avg Revenue beat(8)-1.37%
Revenue beat(12)8
Avg Revenue beat(12)-0.69%
Revenue beat(16)10
Avg Revenue beat(16)5.67%
PT rev (1m)-4.75%
PT rev (3m)-8.07%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)4.63%
EPS NY rev (1m)-2%
EPS NY rev (3m)-3.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.25 | ||
| Fwd PE | 12.81 | ||
| P/S | 0.37 | ||
| P/FCF | 17.34 | ||
| P/OCF | 5.87 | ||
| P/B | 1.19 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.05 |
EPS(TTM)1.15
EY7.02%
EPS(NY)1.28
Fwd EY7.81%
FCF(TTM)0.95
FCFY5.77%
OCF(TTM)2.79
OCFY17.04%
SpS43.97
BVpS13.75
TBVpS-6.1
PEG (NY)1.27
PEG (5Y)N/A
Graham Number18.86
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.44% | ||
| ROE | 8.38% | ||
| ROCE | 6.91% | ||
| ROIC | 5.27% | ||
| ROICexc | 5.3% | ||
| ROICexgc | 10.74% | ||
| OM | 6.17% | ||
| PM (TTM) | 2.62% | ||
| GM | 11.54% | ||
| FCFM | 2.15% |
ROA(3y)3.12%
ROA(5y)3.34%
ROE(3y)13.23%
ROE(5y)17.79%
ROIC(3y)4.28%
ROIC(5y)4.69%
ROICexc(3y)4.32%
ROICexc(5y)4.74%
ROICexgc(3y)8.45%
ROICexgc(5y)10.81%
ROCE(3y)5.62%
ROCE(5y)6.16%
ROICexgc growth 3Y36.24%
ROICexgc growth 5Y-11.26%
ROICexc growth 3Y45.51%
ROICexc growth 5Y-3.96%
OM growth 3Y25.21%
OM growth 5Y-6.51%
PM growth 3Y-8.86%
PM growth 5Y-10.34%
GM growth 3Y9.83%
GM growth 5Y-4.91%
F-Score5
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 15.74 | ||
| Debt/EBITDA | 3.82 | ||
| Cap/Depr | 163.38% | ||
| Cap/Sales | 4.2% | ||
| Interest Coverage | 2.79 | ||
| Cash Conversion | 72.71% | ||
| Profit Quality | 82.03% | ||
| Current Ratio | 1.04 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 1.62 |
F-Score5
WACC8.65%
ROIC/WACC0.61
Cap/Depr(3y)127.38%
Cap/Depr(5y)112.75%
Cap/Sales(3y)4.41%
Cap/Sales(5y)4.06%
Profit Quality(3y)122.64%
Profit Quality(5y)96.78%
High Growth Momentum
Growth
EPS 1Y (TTM)-30.3%
EPS 3Y-2.22%
EPS 5Y-9.36%
EPS Q2Q%223.08%
EPS Next Y11.25%
EPS Next 2Y9.53%
EPS Next 3Y3.71%
EPS Next 5YN/A
Revenue 1Y (TTM)5.12%
Revenue growth 3Y5.76%
Revenue growth 5Y-0.29%
Sales Q2Q%6.41%
Revenue Next Year5.04%
Revenue Next 2Y4.91%
Revenue Next 3Y4.75%
Revenue Next 5YN/A
EBIT growth 1Y25.29%
EBIT growth 3Y32.43%
EBIT growth 5Y-6.78%
EBIT Next Year40.13%
EBIT Next 3Y15.67%
EBIT Next 5YN/A
FCF growth 1Y-60.35%
FCF growth 3Y7.47%
FCF growth 5Y-33.2%
OCF growth 1Y-33.1%
OCF growth 3Y6.75%
OCF growth 5Y-19.55%
SELECT MEDICAL HOLDINGS CORP / SEM Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for SELECT MEDICAL HOLDINGS CORP?
ChartMill assigns a fundamental rating of 4 / 10 to SEM.
What is the valuation status for SEM stock?
ChartMill assigns a valuation rating of 6 / 10 to SELECT MEDICAL HOLDINGS CORP (SEM). This can be considered as Fairly Valued.
What is the profitability of SEM stock?
SELECT MEDICAL HOLDINGS CORP (SEM) has a profitability rating of 5 / 10.
What is the earnings growth outlook for SELECT MEDICAL HOLDINGS CORP?
The Earnings per Share (EPS) of SELECT MEDICAL HOLDINGS CORP (SEM) is expected to grow by 11.25% in the next year.
Can you provide the dividend sustainability for SEM stock?
The dividend rating of SELECT MEDICAL HOLDINGS CORP (SEM) is 5 / 10 and the dividend payout ratio is 21.99%.